These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 31677933)

  • 21. Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic.
    Dadiomov D; Bolshakova M; Mikhaeilyan M; Trotzky-Sirr R
    Harm Reduct J; 2022 Jun; 19(1):69. PubMed ID: 35768817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Orienting patients to greater opioid safety: models of community pharmacy-based naloxone.
    Green TC; Dauria EF; Bratberg J; Davis CS; Walley AY
    Harm Reduct J; 2015 Aug; 12():25. PubMed ID: 26245865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study protocol for the Respond to Prevent Study: a multi-state randomized controlled trial to improve provision of naloxone, buprenorphine and nonprescription syringes in community pharmacies.
    Green TC; Bratberg J; Irwin AN; Boggis J; Gray M; Leichtling G; Bolivar D; Floyd A; Al-Jammali Z; Arnold J; Hansen R; Hartung D
    Subst Abus; 2022; 43(1):901-905. PubMed ID: 35213293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implementation of academic detailing for pharmacists on opioid use disorder and harm reduction.
    DiPaula BA; Cooke CE; Boyle CJ; Love RC
    J Am Pharm Assoc (2003); 2022; 62(1):241-246. PubMed ID: 34690080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implementing an overdose education and naloxone distribution program in a health system.
    Devries J; Rafie S; Polston G
    J Am Pharm Assoc (2003); 2017; 57(2S):S154-S160. PubMed ID: 28233681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beliefs Associated with Pharmacy-Based Naloxone: a Qualitative Study of Pharmacy-Based Naloxone Purchasers and People at Risk for Opioid Overdose.
    Donovan E; Case P; Bratberg JP; Baird J; Burstein D; Walley AY; Green TC
    J Urban Health; 2019 Jun; 96(3):367-378. PubMed ID: 30747371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Public Health and Pharmacy Partnerships in Opioid Harm Reduction: Responding to Community Needs.
    Medina S; Tomaszewski R; Chhen S; Hanson A; Mueller A; Palombi LC
    Prog Community Health Partnersh; 2021; 15(1):37-46. PubMed ID: 33775959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. State laws that authorize pharmacists to prescribe naloxone are associated with increased naloxone dispensing in retail pharmacies.
    Xu J; Mukherjee S
    Drug Alcohol Depend; 2021 Oct; 227():109012. PubMed ID: 34482035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opioid Misuse and Overdose: Changes in Pharmacist Practices and Outcomes.
    Eukel H; Steig J; Frenzel O; Skoy E; Werremeyer A; Strand M
    J Contin Educ Health Prof; 2020; 40(4):242-247. PubMed ID: 33284175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving Community Pharmacist-Delivered Care for Patients With Psychiatric Disorders Filling an Opioid Prescription.
    Werremeyer A; Frenzel O; Strand MA; Eukel H; Skoy E; Steig J
    Psychiatr Serv; 2022 Nov; 73(11):1294-1297. PubMed ID: 35502518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accessing Take-Home Naloxone in British Columbia and the role of community pharmacies: Results from the analysis of administrative data.
    Moustaqim-Barrette A; Papamihali K; Mamdani Z; Williams S; Buxton JA
    PLoS One; 2020; 15(9):e0238618. PubMed ID: 32915834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Public health detailing to increase naloxone access in NYC pharmacies.
    Foster CL; Tuazon E; Winkelstein E; Kunins HV; Kattan JA
    J Am Pharm Assoc (2003); 2023; 63(3):885-892. PubMed ID: 36997471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient Experience and Satisfaction with Opioid-Related Screening and Intervention in North Dakota Community Pharmacies.
    Lothspeich E; Werremeyer A; Chase S; Huseth-Zosel A
    J Pharm Pract; 2023 Oct; 36(5):1217-1224. PubMed ID: 35704458
    [No Abstract]   [Full Text] [Related]  

  • 34. How prepared are pharmacists to provide over-the-counter naloxone? The role of previous education and new training opportunities.
    Lai Joyce Chun K; Olsen A; Taing MW; Clavarino A; Hollingworth S; Dwyer R; Middleton M; Nielsen S
    Res Social Adm Pharm; 2019 Aug; 15(8):1014-1020. PubMed ID: 30926251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Implementing Screening and Interventions to Target Prevention of Opioid Misuse and Accidental Overdose in the Inpatient Setting.
    Bjornson S; Grindeland CJ; Werremeyer AB
    J Pharm Pract; 2024 Apr; 37(2):442-447. PubMed ID: 36472932
    [No Abstract]   [Full Text] [Related]  

  • 36. Changes in Pharmacists' Perceptions After a Training in Opioid Misuse and Accidental Overdose Prevention.
    Eukel HN; Skoy E; Werremeyer A; Burck S; Strand M
    J Contin Educ Health Prof; 2019; 39(1):7-12. PubMed ID: 30614959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reviewing state-mandated training requirements for naloxone-dispensing pharmacists.
    Roberts AW; Carpenter DM; Smith A; Look KA
    Res Social Adm Pharm; 2019 Feb; 15(2):222-225. PubMed ID: 29650444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implementation of a North Dakota Opioid Misuse and Overdose Prevention Program in West Virginia.
    Skoy E; Linger R; Eukel H; Bisset S; Frenzel O; Steig J; Strand M; Werremeyer A
    J Am Pharm Assoc (2003); 2024 Jul; ():102152. PubMed ID: 38964591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time for Pharmacy Co-dispensing of Naloxone with Prescribed Opioids?
    Wunderlich JR; Engelberg RS; Tofighi B; Schwartz MD
    J Gen Intern Med; 2022 Aug; 37(11):2621-2623. PubMed ID: 35581455
    [No Abstract]   [Full Text] [Related]  

  • 40. Integration of Pharmacy Student Interns into a Naloxone Telephone Outreach Service.
    Rothbauer K; Genisot A; Frey T; JohnsonPharmacy William S Middleton Memorial Veterans Hospital D
    J Pain Palliat Care Pharmacother; 2022 Dec; 36(4):208-215. PubMed ID: 35997489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.